Continuous Processing Potential Outside of Traditional Small Molecule & Monoclonal Antibody Applications

Time: 1:05 pm
day: Stream 2 - Day 2


• What technologies are available for cell, gene, and vaccine continuous manufacturing?
• How close are these technologies to commercialization? – How easy are commercially available technologies able to be adapted to process needs?
• What are the drivers for exploring CM for modalities outside of the traditional small molecules & monoclonal antibodies?